CMS Open Payments · Program Year 2024
Guam
Guam received $13,095.98 in pharmaceutical-industry payments to 55 physicians and 0 teaching hospitals across 335 transactions.
- $13.1K
- Total payments
- $10.8K
- To physicians
- $0.00
- To teaching hospitals
- #56
- of 59 states
In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $13.1K in payments to 55 physicians and 0 teaching hospitals in Guam. That ranks Guam #56 of 59 states and territories (0.0% of the US total), averaging $196.67 per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.
The verdict
Guam pairs modest payment volume with a physician-heavy payment mix.
- #56
- of 59 states
- 0.0%
- of the national total
- 82.6%
- to physicians vs. hospitals
- 55
- physicians paid
What the Data Shows for Guam
Guam sits in the lower-volume tercile at #56 of 59 (0.0% of US dollars). The PY2024 file still records $13,095.98 across 335 transactions.
Physician versus hospital mix is near the corpus middle (82.6% / 0.0%). Average transaction $39.09. Leading nature of payment: "Food and Beverage" at $10.5K (80.1% of the state file; top-three natures 98.6%).
Guam sits in the 7th percentile (lower-volume tier). Just above: U.S. Virgin Islands ($17.7K). Just below: American Samoa ($731.62). For context: top-ranked California ($342.4M) is 26144.5× larger than Guam. CMS Sunshine Act framework and methodology.
Physician vs Hospital Payments
How pharmaceutical payments in Guam are distributed between physicians and teaching hospitals.
Physician Payments
$10.8K
82.6% of total · 55 recipients · $196.67 avg
Teaching Hospital Payments
$0.00
0.0% of total · 0 hospitals · $0.00 avg
Payment Breakdown by Type
Guam has 4 types of pharmaceutical payments. "Food and Beverage" accounts for 80.1%.
Nature concentration in Guam
Top three Open Payments natures are 98.6% of state dollars; residual is every other reported nature
Payment categories in Guam
Top categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of State |
|---|---|---|---|
| Food and Beverage | $10.5K | 327 | 80.1% |
| Travel and Lodging | $1.2K | 4 | 9.5% |
| Entertainment | $1.2K | 1 | 9.0% |
| Education | $184.00 | 3 | 1.4% |
Read with this Guam Open Payments read
Volume neighbors, physician-share peers, and the national nature catalog, not the same three guides on every state page.
- Next higher total: U.S. Virgin Islands ($17.7K)
- Next lower total: American Samoa ($731.62)
- Nearest physician-share mix: North Carolina (82.7% to physicians)
- Nearest physician-share mix: Arizona (82.9% to physicians)
- Nearest physician-share mix: New Mexico (82.9% to physicians)
- National catalog for leading nature here: Food and Beverage (80.1% of Guam)
- State payment rankings (includes Guam at #56)
- How Open Payments natures are defined
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.
Read our methodology - how this data is sourced, computed, and verified.
Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024
What Guam totals can and cannot tell you
The aggregate payment figure for Guam measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.
Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.